[IKT] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
29-Sep-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -59.00%
YoY- 44.64%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 1,363 1,407 698 38 220 271 240 218.65%
PBT -2,636 -2,637 -1,208 -671 -422 -547 -430 235.32%
Tax -2,628 -2,625 -2,841 -664 -414 -540 -422 238.86%
NP -2,636 -2,637 -1,208 -671 -422 -547 -430 235.32%
Tax Rate - - - - - - - -
Total Cost 3,999 4,044 1,906 708 641 818 670 229.40%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -193.40 -187.40 -172.95 -1,779.72 -192.12 -202.17 -178.97 5.31%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -1.29 -1.57 -0.87 -0.49 -0.31 -0.40 -0.32 153.51%
EPS Diluted -1.29 -1.57 -0.87 -0.49 -0.31 -0.40 -0.32 153.51%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.